Since the 2023 financing round, Flare’s lead program FX-909 has moved into a phase 1 clinical trial for patients with ...

Flare Therapeutics Inc., a clinical-stage biotechnology company targeting transcription factors to discover precision ...

A representation of transcription factor proteins binding to a strand of DNA. Courtesy LANLLANL NEWS RELEASE To understand ...

To understand the workings of DNA in relation to disease, scientists at Los Alamos National Laboratory have developed the first multimodal deep learning model of its kind, EPBDxDNABERT-2, capable of ...

A pivotal study has uncovered a genetic defense mechanism in lily plants against Botrytis cinerea, the fungus behind gray ...

Flare Therapeutics has entered into a strategic discovery collaboration with Roche. The partnership will leverage Flare Therapeutics' ...

Understanding how roots grow can help us develop plants that—for example—are more resistant to drought. Research by Prof.

September 30, 2024 - SAN MATEO, Calif. and CAMBRIDGE, Mass., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Kronos Bio, Inc. (Nas ...

Discover how cutting-edge research unveiled at ACR Convergence 2024 highlights macrophage-fibroblast interactions and the ...

Data demonstrates Kronos Bio's approach to targeting oncogenic transcription factors and the strong relationship between IRF4 ...